(Q33910771)

English

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Linda Wittkop

1

0 references

Rodolphe Thiébaut

12

object named as

Rodolphe Thiébaut

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

François Dabis

10

object named as

Francois Dabis

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Isabelle Pellegrin

14

object named as

Isabelle Pellegrin

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dominique Breilh

2

object named as

Dominique Breilh

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

object named as

Pierre Duffau

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ANRS CO3 Aquitaine Cohort

15

object named as

ANRS CO3 Aquitaine Cohort

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Daniel Da Silva

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Patrick Mercié

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Isabelle Raymond

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Guerric Anies

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hervé Fleury

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Claude Saux

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Catherine Fagard

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Bernard Masquelier

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

31 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1251-1255

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Minimal pharmacokinetic interaction between the human immunodeficiency virus nonnucleoside reverse transcriptase inhibitor etravirine and the integrase inhibitor raltegravir in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

5 July 2018

Raltegravir with optimized background therapy for resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

5 July 2018

HIV-1 drug resistance mutations: an updated framework for the second decade of HAART

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

5 July 2018

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

5 July 2018

A conventional LC-MS method developed for the determination of plasma raltegravir concentrations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

29 October 2018

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

29 October 2018

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885067

29 October 2018

Update of the drug resistance mutations in HIV-1: Spring 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/19336453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/JAC/DKP114

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33910771&oldid=1858125697"